Science topic
Treatment Planning - Science topic
Explore the latest questions and answers in Treatment Planning, and find Treatment Planning experts.
Questions related to Treatment Planning
Keeping in mind the current bombardment of artificial intelligence in all the fields, including the medical field, dental, as well as orthodontics, and dentofacial orthopedics, is it reliable to be based on AI diagnosis and treatment planning?
The clinical examination of the patient and the psychosocial factors of the patient, which are the heart of diagnosis and treatment planning in orthodontics, are some things that AI may not be able to predict.
Orthodontics has long been considered the most prestigious dental specialty, attracting top candidates and offering high income. But its core — diagnosis, treatment planning, and progress monitoring — is increasingly being absorbed by artificial intelligence.
Let’s be honest: orthodontists rarely do the manual work. Assistants and technicians handle that. The orthodontist’s job is to process diagnostic data — OPGs, cephalograms, intraoral scans, clinical photos — and create a plan.
But what happens when AI does all of that better, faster, and more consistently?
You trained for 3 years.
AI does it in 3 seconds.
With AI-driven analysis, treatment simulation, and automated progress tracking, we are entering an era where a technician — armed with 3D-printed transfer trays and periodic scan uploads — becomes the executor. The brain of the operation is no longer human.
Some still say, “We’re driving the car.” But they’re not. The technician is driving now. The orthodontist isn’t in control anymore. In fact, they may not even be needed.
The AI car is currently manual — it still needs a driver.
Soon, it will be automatic.
Eventually, it will drive itself.
Orthodontics has the highest potential to become a fully self-driving specialty.
Why invest years in training someone for a task that AI already does better?
Let’s discuss.
Generative AI claims to revolutionize the entire healthcare industry, from medical diagnosis to drug discovery, from patient care to personalized treatment plans (I think it will change the entire system); what do you think the pros and cons are?
How can people effectively integrate data from genomics, metabolomics and microbiomics in individualized treatment of cardiovascular disease to achieve more accurate disease prediction and treatment plans ?
Describe a case in which a patient’s social determinants of health significantly impacted their treatment outcomes. How did you address these factors in the treatment plan, and what were the results? Include considerations such as socioeconomic status, access to healthcare, and cultural beliefs.
What specific herbal remedies have shown promising results in preventing or treating urinary stones, and what is the recommended approach for incorporating phytotherapy into a comprehensive treatment plan according to urinary stone type ?
Especially when it comes to applications of AI in health care for diagnosis and treatment planning of diseases.
A man was injured in Port Said, Egypt, in a traffic accident. The attending physician’s report was as shown in the annex, along with a CT scan showing the condition
Do you agree with the treatment plan?
What are the points on which you agree with the attending physician, and points where you disagree with him?
- What medical equipment is supposed to be present?
- What is the ideal degree of follow-up that should be provided to the patient?
In the event that you wish to inquire about more about the case to decide the correctness of your answer, you can contact Port Fouad General Hospital through the following link:

Lip to teeth relationship / Lower third of the face constitutes major part of facial thirds and second most attractive part of face after the eyes in the middle third. Do we have any google play store apps to apply this concept of diagnosing mini-aesthetic problems and providing patients with better aesthetic outcomes?
Please give a significant medical suggestion for endhancing life expectancy and proper treatment plan for a patient clinically diagnosed with periampullary masses, bile duct obstruction and possible liver metastasis.
History: No drug, smoking and drinking habit
Medical history: Long term gastric issues, upper abdominal plane (sometimes), weight loss, slight yellowish eye etc.



Hello, I'm medical physicist, studying my master degree and want some idea for the master project related to proton therapy treatment planning?
if someone here experience about proton therapy and willing to share some ideas, I'd be thankful
I need machine learning algorithm that could be use in health care specially in generating treatment plan.
The treatment of pectus carinatum (PC) has classically been operative, though compressive orthotic braces have been used with good success in recent years. Compressive orthotic bracing is a successful method of treatment of pectus carinatum. The associated sternal rotation can be significantly improved with appropriate bracing that results in a subjective improvement in the deformity. Asymmetry of chest diameter related to concomitant excavatum-type deformity is less likely to respond to bracing attempts. In this way, initial chest CT can be of value in treatment planning.
source:
Hello,
I have a question about treatment protocols and standardization of services in mental health care in the US. I am aware of numerous treatment guidelines and recommendations that have been published, for example by SAMHSA, WHO, NICE, etc. However, it would seem that theses materials function more or less as suggestions rather than as actual standard procedures.
What I would like to locate is data on the services provided in either the treatment of chronic schizophrenia or in the case of first episode psychosis. Specifically, I would like to find information on the treatment plans which are actually constructed and used in routine clinical practice. My suspicion is that there is a significant gap between the quality of services actually provided and those which have been recommended.
This question stems from a perceived overreliance on psychiatric drugs in treating psychotic disorders as well as from the recognition that there seems to be a persistent lag between psychopathology research and clinical practice. This can be seen in our current models of mental illness which is still heavily rooted in the biomedical model dating back to its initial rise to power in the 1950's. And while clinical practice still holds these views as the dominant model in the field, a recent push back against medicalization has gained popularity amongst researchers, and with it, a renewed interest in psychosocial models of treatment.
This leads me to another question about treatment standards for psychotic disorders. If you consider the poor prognosis despite available medication and the generally pessimistic attitudes toward the effectiveness of psychotherapy for psychosis, one would imagine that the development of innovative psychosocial therapies would be of great service to the unmet needs of this population. Accordingly, the literature would suggest that there has indeed been growing interest in this endeavor, and a number of therapies designed specifically for psychosis have been gaining attention. Of these approaches, a few notable examples include Metacognitive Training, ACT for psychosis, AVATAR therapy, Voice Dialogue Therapy, and IMR, among others.
So the question remains, why does it seem that CBTp is still the only intervention regularly employed in mental health care services? (I would also be interested to know how the rates of providing CBTp compare to the use of psychiatric drugs proportionally) Where is it that these alternative therapies are actually being made available to patients, and if they are not, by what process and on what timeline will they become available?
Any input on these matters would be appreciated. I would be particularly interested in locating actual statistical data on these practices. These seem to be important questions to consider, especially if my suspicions are true. From my perspective, the bias resulting from the overemphasis of a biomedical model in conjunction with a lack of enforcement of standardized protocols leads to an environment which carries significant risk of resorting to ineffective, poor quality services.
I know how to calculate the MU time but not sure how to get the cumulative dose. I have gone through the Radiation Physics book by Faiz. However no clear cut approach is shown for getting the cumulative dose? So my question is 1) Is there any approach by which cumulative dose can be calculated? or it is prescribed by the radiologist? 2) Do we need to optimize the dose distribution for telecobalt therapy?
I have seeded 10000 cells/100 ul media/well of a 96 well plate and want to treat them with 1, 2, 5, 10, 25, 50 & 100 ug of a protein extract, having concentration 1.8 ug/ul,to know the cytotoxic effect. Is it be ok to add 1, 2, 5...... ul of protein extract or I should calculate protein concentration for 100 ul as I'm seed total of 100 ul in each well.
Thanks for your time for me. My query is on the radiation therapy process for a cancer patient.
How radiation simulation and marking process is done prior to radiation therapy for a cancer patient?
Any kind of explanatory video /animation/ documents from the basic level is best for me to understand it as I have absolute zero knowledge about the whole process.
Regards,
Bhaskar
Digitally Reconstructed Radiograph (or DRR) that is created from a computed tomography (or CT) data set. This image would contain the same treatment plan information, but the patient image is reconstructed from the CT image data using a physics model.
I need some training on the use of Matlab, Monte Carlo, C++ for image processing, image reconstruction, analysis, radiation dosimetry and treatment planning.
I wanted to calculate gamma-3d index for RT dose file ( the output of Treatment planing system) and 3ddose file( the output of dosxyznrc monte carlo code). for this purpose I added the above files to the CERR software and run the gamma-3d function.but when CERR tried to sum these two function for calculating gamma index وin the command window the following errors appeared
"Index exceeds matrix dimensions.
Error in finterp3 (line 135)
interpV = double(field3M(INDEXLIST)) .*
oneMinusRowMod .* oneMinusColMod .*
oneMinusSlcMod;
Error in slice3DVol (line 161)
slc = finterp3(xM(:), yM(:), zM(:),
data3M(maxY:minY, minX:maxX, minZ:maxZ),
xVec, fliplr(yVec), zVec, 0);
Error in prepareDosesForGamma (line 106)
doseTmp = slice3DVol(dA, xV, yV, zV,
newZgrid(slcNum), 3, 'linear',
inputTM, [], newXgrid, newYgrid);
Error in createGammaDose (line 19)
[newXgrid, newYgrid, newZgrid, doseArray1,
doseArray2] =
prepareDosesForGamma(doseNum1,doseNum2,1, planC);
Error in CERRGammafnc (line 211)
createGammaDose(baseDose,refDose,doseDiffIN,DTA,threshold);
Error while evaluating UIControl Callback"
how do I correct these errors?
please help me
thanks in advance to your attention or maybe your help.
A case format attached which can be modified...
A male patient who had a Kidney transplant in 2010 has developed slow growing malignant prostrate cancer.
With this complication what would the best treatment plan to address the cancer without damaging the new kidney be please?
Please elaborate on the surgical steps.




From the teffects documentation in Stata 14, I see that the margins command may be used to calculate the conditional ATE or ATET for a subpopulation for etpoisson and etregress.
Both etpoisson and etregress also take complex survey weights (using svy, pweight, etc.). However, the margins post-estimation command does not. It seems like my options are to re-parameterize etregress as needed, or ignore the biased standard errors.
Specifically, I want to model a treatment - covariate interaction (treatment * income). The example on page 49 of the documentation shows how to calculate the interaction, but does not use the complex survey weights.
A 3o yrs pregnant woman " golden baby" with a mass in right breast, CNB result: invasive ductal carcinoma grade II ER + PR+ HER2+. No familial breast cancer history. sonography axial was negative.what is your plan.
1.Root planning/Curettage/Flap surgey
2.Root conditioning/Local irrigation?
3. RCT
4. Crown
5. Extraction of hopeless tooth
People with morbid obesity are admitted to hospitals and practice centers for a broad array of conditions, such as broken bones, pregnancy, or skin rashes`. Given the brief treatment episodes that are the norm for primary presenting complaint, what are the training/ educational needs for health care professionals when they come across this type of patient? I believe this is a special population.at risk for inadequate treatment plans and psychological harm from stigmatizing attitudes.
Thank you
The particular research study am conducting research about the efficacy of the “strengths” component in treatment plans for substance abuse, particularly with adolescents. My research focuses on 2 areas:
When and why did the inclusion of “strengths” in the treatment plan begin?
What research is out there to show if it is helping with outcomes or not?
I was wondering if anyone could point me in the direction of resources?
Many thanks
Christine Rhodes
Is it possible to achieve favorable maxillofacial re-construction from a natural and physiological standpoint, if implant placement is involved during treatment planning?
When an IMRT treatment is planned for 20 fractions and if we want to check the cumulative DVH delivered after 10 fractions such that we can do an off line adaptive planning. What is the standard procedure followed. The machine is a 6MeV linac with Kv IGRT.
a non obstructing tumor in hepatic flexure with a simultaneously T2N1 rectal ca without distant metastasis
with is your treatment plan?
Greetings! I am an entrepreneur who is working with some colleagues to develop an application that allows AFIB patients to keep track of the occurrence of episodes and their length. The advantage of this application is that the information can be shared with their health care provider at the time of service to allow them to design treatment plans to improve the quality of care and reduce the cost of repeated care for their office.
We are interested in talking to health care providers and researchers involved with AFIB to hear what sort of information would be most valuable to them. We have an outline of the remote monitoring system and would like to get some feedback on features that would provide the greatest value to both health care provider and patient. If you have any thoughts that you could share with us in the body of this question or we would be able to discuss and share our current prototypes offline to get your feedback (please PM me for details).
Thanks very much for your help, we're looking forward to hearing from you!